eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Forum Health Products Limited

Forum Health Products Limited, Betchworth House, 57/65 Station Road, Redhill, Surrey, RH1 1DL
Telephone: +44 (0)1737 857 782
Fax: +44 (0) 1737 857701
WWW: http://www.forum.co.uk
Medical Information Direct Line: 0500 455 456
Customer Care direct line: 0500 455 456

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 29/07/2010
SPC Fybogel Orange


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Fybogel Orange.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

A unit dose (one sachet or two level 5 ml spoonfuls) contains 3.5 g ispaghula husk BP.


Go to top of the page
3. PHARMACEUTICAL FORM

Effervescent granules.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

The treatment of patients requiring a high fibre regime: for example, for the relief of constipation, including constipation in pregnancy and the maintenance of regularity; for the management of bowel function in patients with colostomy, ileostomy, haemorrhoids, anal fissure, chronic diarrhoea associated with diverticular disease, irritable bowel syndrome and ulcerative colitis.


Go to top of the page
4.2 Posology and method of administration

Fybogel Orange is intended for oral use as a suspension in a drink of water. The granules should be stirred into a glass of water and taken as soon as the effervescence subsides, preferably after meals.

Adults and children over 12 years:

One sachet or two level 5ml spoonfuls morning and evening.

Elderly:

There is no indication that dosage needs to be modified for the elderly.

Children aged 6 to 12 years:

Half to one level 5 ml spoonful, depending on age and size, morning and evening.

Children under 6 years:

To be taken only when prescribed by a doctor, half to one level 5 ml spoonful depending on age and size, morning and evening.


Go to top of the page
4.3 Contraindications

Fybogel Orange is contraindicated in cases of intestinal obstruction, faecal impaction and colonic atony such as senile megacolon.


Go to top of the page
4.4 Special warnings and precautions for use

Due to its aspartame content Fybogel Orange should not be given to patients with phenylketonuria.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

Fybogel Orange may be used during pregnancy and lactation since the ispaghula husk is not absorbed from the gastrointestinal tract.


Go to top of the page
4.7 Effects on ability to drive and use machines

None.


Go to top of the page
4.8 Undesirable effects

A small amount of abdominal distension and flatulence may sometimes occur.


Go to top of the page
4.9 Overdose

In the event of overdosage conservative measures should be taken. The patient may notice abdominal discomfort and flatulence, and attention should be paid to maintaining an adequate fluid intake, particularly if the granules have been taken without water contrary to administration instructions.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Ispaghula husk is capable of absorbing up to 40 times its own weight in water in vitro, and part of its activity can be attributed to its action as a simple bulking agent. In addition, colonic bacteria are believed to use the hydrated material as a metabolic substrate. This results in an increase in the bacterial cell mass with consequent softening of the faeces.


Go to top of the page
5.2 Pharmacokinetic properties

The mode of action of Fybogel Orange is physical and does not depend on absorption into the systemic circulation.


Go to top of the page
5.3 Preclinical safety data

No preclinical findings relevant to the prescriber have been reported.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Potassium bicarbonate

USP

Sodium bicarbonate

Ph Eur

Citric acid

Ph Eur

Riboflavin sodium phosphate

Ph Eur

Beta-carotene 10% (E160a)

HSE

Aspartame

Ph Eur

Orange flavour

HSE

Saccharin sodium

Ph Eur

Polysorbate 80

Ph Eur

Silica, colloidal anhydrous

Ph Eur


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

Three years.


Go to top of the page
6.4 Special precautions for storage

Store below 30°C in a dry place.


Go to top of the page
6.5 Nature and contents of container

Sachets, one, seven, ten or thirty sachets enclosed in a carton. Tub containing 100-300 g Fybogel Orange.


Go to top of the page
6.6 Special precautions for disposal and other handling

Fybogel Orange granules are to be dispersed in water forming a drink.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Reckitt Benckiser Healthcare (UK) Limited,

Dansom Lane,

Hull,

HU8 7DS.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00063/0026


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

24th April 1995 / 26th June 1997.


Go to top of the page
10. DATE OF REVISION OF THE TEXT

19/01/2007



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/6859/SPC/


Active Ingredients/Generics

 
   ispaghula husk